Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
pediatrics (2) 2
pulmonary hypertension (2) 2
survival (2) 2
5 inhibitor therapy (1) 1
6-minute walk distance (1) 1
abridged index medicus (1) 1
adolescent (1) 1
bosentan (1) 1
cardiology and cardiovascular medicine (1) 1
cardiovascular (1) 1
cardiovascular disease (1) 1
care and treatment (1) 1
child (1) 1
child, preschool (1) 1
children & youth (1) 1
classification (1) 1
clinical trials (1) 1
critical care medicine (1) 1
defects (1) 1
double-blind (1) 1
drug therapy (1) 1
efficacy (1) 1
endothelin receptor antagonist (1) 1
endpoint determination (1) 1
female (1) 1
genetic disorders (1) 1
heart (1) 1
heart diseases (1) 1
hospitals (1) 1
humans (1) 1
hypertension, pulmonary - mortality (1) 1
hypertension, pulmonary - physiopathology (1) 1
incidence (1) 1
index medicus (1) 1
internal medicine (1) 1
male (1) 1
management (1) 1
medical prognosis (1) 1
netherlands - epidemiology (1) 1
oral treprostinil (1) 1
prognosis (1) 1
prospective studies (1) 1
prostanoids (1) 1
pulmonary/respiratory (1) 1
randomized controlled-trial (1) 1
ratios (1) 1
registries (1) 1
research (1) 1
respiratory system (1) 1
retrospective studies (1) 1
reveal registry (1) 1
sildenafil citrate (1) 1
sitaxsentan (1) 1
trial designs (1) 1
usage (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Survival Differences in Pediatric Pulmonary Arterial Hypertension
by Zijlstra, Willemijn M.H., BSc and Douwes, Johannes M., MD and Rosenzweig, Erika B., MD and Schokker, Sandor, BSc and Krishnan, Usha, MD and Roofthooft, Marcus T.R., MD, PhD and Miller-Reed, Kathleen, RN and Hillege, Hans L., MD, PhD and Ivy, D. Dunbar, MD and Berger, Rolf M.F., MD, PhD
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2014, Volume 63, Issue 20, pp. 2159 - 2169
Objectives In order to describe survival and treatment strategies in pediatric pulmonary arterial hypertension (PAH) in the current era of PAH-targeted drugs... 
Cardiovascular | Internal Medicine | pulmonary hypertension | pediatrics | survival | Pediatrics | Genetic disorders | Heart diseases | Pulmonary hypertension | Heart | Ratios | Hospitals | Medical prognosis | Classification | Cardiovascular disease | Drug therapy | Children & youth | Defects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Clinical Worsening as Composite Study End Point in Pediatric Pulmonary Arterial Hypertension
by Ploegstra, Mark-Jan, MD and Arjaans, Sanne, BSc and Zijlstra, Willemljn M.H., BSc and Douwes, Johannes M., MD and Vissia-Kazemier, Theresia R., RN, MANP and Roofthooft, Marcus T.R., MD, PhD and Hillege, Hans L., MD, PhD and Berger, Rolf M.F., MD, PhD
Chest, ISSN 0012-3692, 2015, Volume 148, Issue 3, pp. 655 - 666
BACKGROUND Clinical worsening (CW), an increasingly used composite end point in adult pulmonary arterial hypertension (PAH), has not yet been evaluated in... 
Pulmonary/Respiratory | SURVIVAL | 5 INHIBITOR THERAPY | REVEAL REGISTRY | SITAXSENTAN | SILDENAFIL CITRATE | 6-MINUTE WALK DISTANCE | DOUBLE-BLIND | RANDOMIZED CONTROLLED-TRIAL | ORAL TREPROSTINIL | ENDOTHELIN RECEPTOR ANTAGONIST | EFFICACY | RESPIRATORY SYSTEM | TRIAL DESIGNS | BOSENTAN | CRITICAL CARE MEDICINE | Hypertension, Pulmonary - mortality | Prognosis | Prospective Studies | Humans | Netherlands - epidemiology | Child, Preschool | Hypertension, Pulmonary - physiopathology | Male | Incidence | Adolescent | Endpoint Determination | Female | Registries | Retrospective Studies | Child | Pediatrics | Care and treatment | Usage | Clinical trials | Management | Research | Pulmonary hypertension | Prostanoids
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.